Drug Industry

Order of the National Green Tribunal regarding an illegal cracker unit in Thanjavur district, Tamil Nadu, 29/05/2025

Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …

Health Min Bans Two Painkiller & Diabetes Drugs; Industry Protests

The health ministry has suspended the sale of two drugs — painkiller Analgin and anti-diabetes drug Pioglitazone and all its combinations. While the ban on Analgin in India has come after almost 36 years after the drug was banned in the US (which banned it in 1977), Pioglitazone was pulled …

Drug companies need to follow EU standards from July 2

NEW DELHI: The government issued new guidelines on Thursday that require India's drugs companies to comply with the Good Manufacturing Practice (GMP) standards of the European Union to ensure pharmaceuticals exports to the 27-country region continue unrestricted. The directive, which will become effective from July 2, prescribes standards for the …

Drugs (Prices Control) Order, 2013

Drugs (Prices Control) Order, 2013 has directions to manufacturers of active pharmaceutical ingredients or bulk drugs or formulations and it states that the Government may, - with a view to achieve adequate availability and to regulate the distribution of drugs, in case of emergency or in circumstances of urgency or …

Order of the National Green Tribunal, Principal Bench, New Delhi in the matter of Advik Laboratories Ltd. & Anr. V/s State Government of Haryana & …

Order of the National Green Tribunal, Principal Bench, New Delhi in the matter of Advik Laboratories Ltd. & Anr. V/s State Government of Haryana & Ors on air pollutants emitted by the polluting industry -Capital Auto Rubber Products (P) Ltd dated 13/05/2013.

A new test to spot pancreatic cancer

15-Year-Old American Develops A Faster, Cheaper Way For Early Detection A15-year-old high school student in the US, whose uncle died of pancreatic cancer, has developed the first test for the disease that could detect tumours before they become too advanced to treat. Pancreatic cancer has the lowest survival rate for …

Drug regulator to periodically inspect all clinical trial sites

Move to ensure compliance with recent guidelines; discrepancies to attract severe action The country's apex drug regulator plans periodic inspection of clinical trial sites to ensure these comply with the recently issued guidelines. If discrepancies are found, strict action is to be taken against the company and the trials might …

In 7 years, 438 drug samples fail quality tests in state

A report submitted to the State Human Rights Commission (SHRC) by the Drugs and Food Control Organisation (DFCO), a state government agency, has revealed that 438 medicines, including inject-able drugs have been found ‘not of standard quality’ (NSQ) after analysis over the past seven years. These samples were lifted randomly …

‘Drug trials being held for profit’

Some Private Hospitals Come Under Attack From Govt-Appointed Panel Thiruvananthapuram: The committee appointed by the government to look into the human drug trials has found that several companies in the state are conducting trials with just profit as their motive. To regulate this, the committee headed by Kerala State Council …

Patients win Patent War

It's double trouble for global pharma companies in India. On April 1, a Supreme Court bench comprising Judges Aftab Alam and Ranjana Desai dismissed Swiss drug major Novartis AG's seven-year-old plea seeking patent protection for its blood cancer drug Imatinib Mesylate, sold as Glivec. The court held that Glivec was …

No to 'ever-greening'

The Pharmaceutical Research and Manufacturers of America and the United States India Business Council are miffed over the recent Novartis judgment of the Supreme Court (SC) of India. For us, however, this ruling on the question of the patentability of the beta crystalline form of Imatinib Mesylate (IM) is one …

Right to affordable drugs upheld: activists

“The court has recognised the right of patients to access affordable medicines over profits for big pharma companies” It was celebration time for health activists and civil society groups after the Supreme Court delivered its judgment dismissing Swiss multinational company Novartis’ appeal for patent for its anti-cancer medicine imatinib mesylate …

USFDA okays safer diabetes drug which acts on kidneys

A novel anti-diabetic drug that lowers blood glucose levels by acting on the kidneys, instead of the liver or the pancreas, has been approved by the USFDA. The drug, Invokana (Canagliflozin), works by blocking the reabsorption of glucose by the kidney, increasing glucose excretion and lowering blood glucose levels in …

Two ayurvedic drugs hold out hope for Alzheimer’s patients

It's a disease long associated with the elderly but is now diagnosed in younger people as well and with no permanent cure available till date. However, in what could give hope to thousands suffering from Alzheimer's Disease (AD), the pharmacology department in AIIMS has identified Ayurvedic drugs which could have …

Challenges in administering a clinical trials registry: Lessons from the Clinical Trials Registry-India

The Clinical Trials Registry - India (CTRI), an online system (www.ctri.nic.in) for the registration of clinical trials being conducted in India, has its secretariat at the National Institute of Medical Statistics of the Indian Council of Medical Research in New Delhi. The primary objective of the CTRI is to ensure …

Novartis plea for patent of cancer drug: Supreme Court verdict today

The Supreme Court will pronounce on Monday its verdict in a landmark patent case involving Swiss pharma giant Novartis AG. The company has challenged the denial of patent to its blood cancer drug Glivec in India The verdict, which is crucial even for public health, is being watched closely by …

Supreme Court judgement dated 01-04-2013:in Appeal Civil No. 2706-2716/2013 @ SLP(C) 20539-20549/2009 Novartis AG Vs. Union of India and ors (Patent/Cancer Drug)

Supreme Court judgement dated 01-04-2013:in Appeal Civil No. 2706-2716/2013 @ SLP(C) 20539-20549/2009 Novartis AG Vs. Union of India and ors (Patent/Cancer Drug).

Policy soon for drug approval, clinical trials

Move comes in the wake of repeated slamming by the SC and the Parliamentary committee on health and family welfare The government is considering framing a separate policy for the approval of medicines, as well as clinical trials conducted in India - in a move that is expected to strengthen …

State all set to introduce new pentavalent vaccine

INDORE: Madhya Pradesh government is all set to introduce a 'controversial' vaccine whose efficacy is still being debated in the country and elsewhere as some deaths of children were reported after they were administered the vaccine. Much against caution by experts', Madhya Pradesh is mulling to launch pentavalent vaccine in …

Govt unveils pharma policy

Health and Family Welfare Minister Aravinda Limbavali has invited pharmaceutical companies in Karnataka set up their plants across the State instead of focussing only on Bangalore. Releasing the Karnataka Pharmaceutical Policy, 2012, here on Wednesday the minister said that many foreign pharmaceutical companies were willing to set up their plants …

Union govt's 'list' exposes state's clinical trial claims

INDORE: While the Union government on Tuesday provided an updated list of 44 clinical trial victims compensated in between 2005 and 2012, experts have raised fingers over the institutional ethics committee of Mahatma Gandhi Memorial Medical College (MGM) alleging it with inaction for not recommending a single victim for compensation …

  1. 1
  2. ...
  3. 14
  4. 15
  5. 16
  6. 17
  7. 18
  8. ...
  9. 73

IEP child categories loading...